Conducted the following in-vivo study of twenty patients.
12 men and 8 women, were selected for this in study.
The average age was 49.3.
The twenty individuals were each level 3 or level 4 cancer
patients.
Each patient was basically sent home by his or her oncologist
to die.
The average life expectancy was 3.7 months.
The protocol was to place each patient on 9 capsules per
day of Transfer Factor Plus™.
The patients was given a number of other *general nutrients.
After eight months, 16 of these individuals were still living
and were either in remission, improving or stabilized.
The baseline for natural killer cell function was 12.4.
Within 4 weeks, the average NK Cell function was increased to 25.7 and in
6 months, it increased to 27.6.
This represented a 233% increase in NK Cell function.
This is an ongoing study. This study has been submitted to a peer reviewed
publication.
also given were*Antioxidants, Digestive Enzymes, Probiotics,
and mult-vitamins.
Dr. See received his degree from the University of California,
Irvine. Academic appointments include: Assistant/Associate Clinical Professor
of Medicine: Investigator, California Collaborative Treatment Group: and
Infectious Disease Consultant, Liver Transplantation Service. He has received
contracts, grants, and research awards from Pfizer Pharmaceuticals, Upjohn
Pharmaceuticals, Roche Molecular Systems, Harvard Biotechnology, National
Institutes of Health, Department of Defense, andmore.
